News And Announcements
Pets at Home cuts full-year profit outlook
Pets at Home cut its full-year profit outlook on Wednesday as it highlighted a "subdued" market.
StanChart exploring sale of wealth & retail banking businesses in Africa
Standard Chartered said on Wednesday that it is exploring the potential sale of its wealth & retail banking (WRB) businesses in Botswana, Uganda and Zambia.
Auction Technology Group posts solid FY numbers
Online marketplace operator Auction Technology Group posted strong full-year numbers on Wednesday, leading it to provide some solid guidance.
Supermarket loyalty pricing not disadvantaging consumers - CMA
The Competition and Markets Authority (CMA) published its findings on loyalty pricing in the UK grocery sector on Wednesday, concluding that such practices were not creating unfair disadvantages after a nearly year-long review.
'Challenging' conditions hit earnings at Johnson Matthey
Johnson Matthey posted a drop in sales and profits on Wednesday, weighed down by the "challenging" macroeconomic backdrop.
Sunrise Resources completes offload of Crow Springs mining claims
Sunrise Resources announced on Wednesday that it has received the final payment of $75,000 from Dicalite Management Group, completing the $150,000 sale of mining claims in the Crow Springs area of Nevada.
Aston Martin raises £210m to support growth and help liquidity
Luxury carmaker Aston Martin has announced it has raised £210m through share and private debt placings to support its growth and investment strategy and shore up its balance sheet, one day after announcing its second profit warning within two months.
Pennon Group swings to half-year loss
Pennon Group reported a statutory loss before tax of £38. 8m for the first half on Wednesday, swinging from a profit of £3. 2m year-on-year, as restructuring costs and investments weighed on the bottom line despite a 17. 5% increase in underlying revenue to £527. 2m.
GSK's liquid meningitis vaccine approved by EU regulators
GSK's liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process against invasive meningococcal disease (IMD).